On Sept. 21, 2017, MilliporeSigma, the life-science subsidiary of Merck KGaA, announced the opening of its first end-to-end biodevelopment center in the Asia Pacific (APAC) region. The center, located in Shanghai, China, will provide a range of process development capabilities and services, inclOriginal Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.